Drug Patents owned by Belcher
1. List of Epinephrine drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10039728 | BELCHER | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(11 years from now) | |
| US10004700 | BELCHER | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(11 years from now) | |
| US9283197 | BELCHER | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(11 years from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 29 July, 2014
Treatment: Increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; Emergency treatment of allergic reactions (type 1), including anaphylaxis; A method of treating allergic reaction, anaphylaxis, anaphylactic shock, or combination thereof by an injection of at least one dosage of the injectable liquid pharmaceutical; Emergency treatment of allergic reactions (type i), including anaphylaxis; Induction and maintenance of mydriasis during intraocular surgery
Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS; SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic